logo

For the Inventor, By the Inventor

Milan, Italy

Umberto Guzzi

This inventor holds 43 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi, Sanofi-Synthelabo, Gruppo Lepetit. Active years: 1980-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Umberto Guzzi. Retrieved from https://idiyas.com/inventor/umberto-guzzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 43

% Patents Active = 88.4

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 167(Granted Patents)


Location History:

  • Vanzago-Milano, IT (2003)
  • Milan, IT (1980 - 2008)

Company Filing History:

goldMedal21 out of 1,562 
 
Sanofi
 patents
silverMedal7 out of 152 
 
Sanofi-Synthelabo
 patents
bronzeMedal6 out of 188 
 
Gruppo Lepetit
 patents
4. 5 out of 53 
 
Elf Sanofi
 patents
5. 4 out of 390 
 
Sanofi-Aventis
 patents

Years Active: 1980-2008

Loading Chart...
Areas of Expertise:
Tetrahydropyridines
Pharmaceutical Compositions
Neurotrophic Compounds
5-HT Agonists
Alzheimer's Treatment
Enzymatic Processes
Tricyclic Compounds
Phenylethanolamines
Heteroarylpiperidines
Optically Active Tetralin
TNF Inhibiting Activity
43 patents (USPTO):Explore Patents
1. 7320982 - Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 (2008-01-22),
2. 7297799 - Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof (2007-11-20),
3. 7151107 - Use of benzoylalkyl-1,2,3,6-tetrahydropyridines (2006-12-19),
4. 6936621 - Use of benzoylalkyl-1,2,3,6-tetrahydropyridines (2005-08-30),
5. 6693118 - Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-&bgr;1 (2004-02-17),
6. 6649627 - Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same (2003-11-18),
7. 6509351 - Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activity (2003-01-21),
8. 6358965 - Use of benzoylalkyl-1,2,3,6-tetrahydropyridines (2002-03-19),
9. 6342505 - Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-&bgr;1 (2002-01-29),
10. 6124318 - Diphenylalkyl-tetrahydropyridines, process for their preparation, and (2000-09-26),
11. 6034090 - 1-Phenylalkyl-1,2,3,6-tetrahydropyridines for treating Alzheimer's (2000-03-07),
12. 5981754 - 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and (1999-11-09),
13. 5723611 - Heteroarylpiperidines (1998-03-03),
14. 5719308 - Enzymatic process for the preparation of optically active tetralin (1998-02-17),
15. 5618822 - N-substituted trifluoromethylphenyltetrahydropyridines, process for the (1997-04-08),

Title: Umberto Guzzi - Pioneering Inventor from Milan

Introduction: Umberto Guzzi is a renowned inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Guzzi's latest patents include a revolutionary design for a sustainable energy generator and a cutting-edge medical device aimed at improving patient care and treatment outcomes.

Career Highlights: Throughout his illustrious career, Umberto Guzzi has been recognized for his exceptional problem-solving skills and creative thinking, leading to the development of numerous patented inventions that have had a significant impact on industries worldwide.

Collaborations: Guzzi has collaborated with leading research institutions, universities, and companies to further his inventions, showcasing his ability to work effectively in multidisciplinary teams to bring ideas to life.

Conclusion: Umberto Guzzi's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a pioneering inventor in Milan and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…